Liraglutide is a daily GLP-1 receptor agonist — the first GLP-1 medication approved specifically for weight loss (as Saxenda). Produces 8-12% average body weight loss. Daily injection provides consistent appetite control. While it achieves less weight loss than weekly semaglutide or tirzepatide, liraglutide has the longest safety track record of any GLP-1 weight loss medication, more accessible pricing in Malaysia (~RM895/month), and suits patients who prefer gradual, steady progress.
What is Liraglutide?
Liraglutide is a GLP-1 receptor agonist developed by Novo Nordisk — the same company that later developed semaglutide (Ozempic/Wegovy). It was the original GLP-1 weight loss medication: first approved by the FDA for diabetes in 2010 (as Victoza) and for chronic weight management in 2014 (as Saxenda). This makes it the longest-studied GLP-1 medication for weight loss, with over a decade of real-world safety data.
Unlike semaglutide and tirzepatide which are injected weekly, liraglutide is a daily injection. This daily dosing provides more consistent blood levels throughout each day, resulting in steady appetite control without the minor fluctuations that some weekly-injection users experience mid-week.
Liraglutide is a 97% structural analogue of native human GLP-1. It includes a fatty acid chain (C16 palmitic acid) that enables it to bind to albumin in the blood, extending its half-life from the natural GLP-1's 2 minutes to approximately 13 hours — long enough for once-daily dosing but not weekly like semaglutide (which uses a longer C18 fatty diacid chain for its 7-day half-life).
Clinical trials (the SCALE program) demonstrated average weight loss of 8-12% of body weight over 56 weeks. While this is less than semaglutide's 15-20% or tirzepatide's 20-25%, it is still clinically meaningful — and liraglutide comes with advantages in established safety data, pricing, and suitability for certain patient profiles.
Saxenda vs Victoza
Same molecule, different doses. Saxenda and Victoza are identical liraglutide — the difference is Saxenda goes up to 3.0mg daily (the dose needed for meaningful weight loss) while Victoza caps at 1.8mg (sufficient for diabetes management but suboptimal for weight loss). For weight management purposes, Saxenda's higher dosing is what produces the clinical trial results.
How It Works
GLP-1 receptor activation: Like semaglutide, liraglutide activates GLP-1 receptors in the hypothalamus (appetite centres), gut (gastric emptying), and pancreas (insulin release). The mechanism is identical — the difference is duration and potency, not pathway.
Appetite suppression: Reduces hunger signals and increases satiety. Users eat less without the willpower struggle of traditional dieting. Food thoughts quiet, portions naturally shrink, and cravings (especially for high-calorie processed foods) diminish.
Delayed gastric emptying: Slows the rate at which food leaves the stomach. You feel physically full for longer after each meal. This contributes to reduced caloric intake.
Improved insulin dynamics: Enhances glucose-dependent insulin secretion (only boosts insulin when blood sugar is elevated, avoiding hypoglycemia risk in non-diabetics). Suppresses glucagon. Improves overall insulin sensitivity over time.
Daily consistency: Because liraglutide is injected daily (vs weekly for semaglutide), blood levels remain more stable throughout the week. Some patients report that weekly injections produce a pattern of stronger appetite suppression for 3-4 days post-injection, followed by a partial return of appetite before the next dose. Liraglutide's daily dosing avoids this entirely.
Liraglutide vs Semaglutide: Honest Comparison
Honest assessment: Semaglutide is the more effective medication for raw weight loss numbers. If maximum weight loss is your primary goal and budget is not a constraint, semaglutide or tirzepatide will likely produce better results. Liraglutide's advantages are in its established safety record, lower cost, more consistent daily appetite control, and suitability for patients who may not tolerate the larger weekly dose bolus of semaglutide.
Who Should Choose Liraglutide?
Liraglutide is not the most powerful GLP-1 medication — but it is the right choice for specific patient profiles:
Cost-Conscious Patients
At ~RM895/month, liraglutide is the most affordable GLP-1 option in Malaysia. For patients who need long-term medication, this price difference compounds significantly over 12-24 months
Moderate Weight Goals (10-20 kg)
If you need to lose 10-20 kg rather than 25+, liraglutide provides sufficient efficacy at lower cost. Not every patient needs the maximum-strength option
Safety-First Patients
With FDA approval since 2010 and millions of patient-years of real-world data, liraglutide has the longest and most thoroughly documented safety profile of any GLP-1 medication
Semaglutide GI Non-Tolerators
Some patients experience significant nausea with weekly semaglutide injections. Liraglutide's daily dosing provides smaller, more gradual GLP-1 exposure that can be better tolerated
Daily Routine Preference
Some patients prefer the consistency of a daily medication they take at the same time every day, rather than remembering which day of the week is injection day
Cardiovascular Risk Patients
The LEADER trial proved liraglutide reduces cardiovascular events (heart attack, stroke, CV death) by 13% in high-risk patients. Established cardioprotective benefit with extensive long-term data
What to Expect (Month by Month)
Starting Phase (0.6mg daily)
Initial dose. Subtle appetite effects — you may notice slightly smaller portions feel satisfying. Mild nausea possible, especially in the first 2-3 days. Most users adjust quickly. Weight loss: 0-1 kg. The daily injection routine becomes second nature within a few days.
Building Phase (1.2-1.8mg daily)
Appetite suppression becomes noticeable. Portions naturally shrink without conscious effort. Sugar and snack cravings begin to diminish. Weight loss: 1-3 kg. Energy levels stable. You start noticing that you forget about food between meals — the constant background "food noise" reduces.
Therapeutic Phase (2.4-3.0mg daily)
Full therapeutic dose reached. Appetite control is strong and consistent throughout each day. Weight loss accelerates: 3-5 kg cumulative. Clothes fit differently. Bloodwork begins improving — fasting glucose drops, insulin sensitivity improves. GI side effects have largely resolved. Daily injection takes 30 seconds.
Steady Progress
Consistent weight loss of 0.5-1 kg per week. 6-10 kg cumulative by month 4-5. Relationship with food fundamentally changes — eating becomes fuel-driven rather than emotion-driven. Blood pressure improves. Inflammatory markers decrease. Joint pain reduces as weight drops. Sleep quality improves.
Sustained Results
8-12% total body weight loss (8-12 kg for a 100 kg starting weight). Weight loss rate naturally slows as the body approaches a new equilibrium. Focus shifts to maintaining results and building sustainable habits. Bloodwork shows clear improvements in metabolic markers. Quality of life improvements — more energy, better mobility, improved mood, better sleep.
Titration Schedule
Liraglutide uses a 5-step weekly titration to reach the therapeutic dose of 3.0mg. Each step is one week minimum:
0.6mg daily
Starting dose. Not therapeutic for weight loss — purely for GI adaptation. Inject at the same time each day (morning or evening, your preference). Can be taken with or without food.
1.2mg daily
First dose increase. Mild appetite effects may begin. Some nausea possible for 1-2 days after the step-up. If significant, stay at 0.6mg for an additional week before increasing.
1.8mg daily
Appetite suppression becomes more noticeable. This is the Victoza max dose (for diabetes). Weight loss begins in earnest. GI system is adapting.
2.4mg daily
Strong appetite control. Significant reduction in cravings and food thoughts. Most GI side effects have resolved. Weight loss is steady.
3.0mg daily (maintenance)
Full Saxenda dose. Maximum appetite suppression and weight loss efficacy. This is the dose used in SCALE clinical trials that produced the 8-12% weight loss results. Some patients find their optimal dose at 2.4mg and stay there.
Side Effects & Safety
Liraglutide has the most extensive real-world safety database of any GLP-1 weight loss medication — over a decade of post-marketing surveillance and millions of patients:
Very common (20-40%): Nausea — the most common side effect, typically mild and resolving within 1-2 weeks at each dose level. Eating slowly, avoiding fatty foods, and not overfilling the stomach helps significantly. Daily dosing means the GI system adapts more gradually than with weekly medications.
Common (10-20%): Diarrhea, constipation, vomiting. Related to the gastric emptying mechanism. Most frequent during titration. Resolved for the majority of users by the time they reach the maintenance dose.
Less common (1-5%): Headache, dizziness, abdominal pain, fatigue, dyspepsia, injection site reactions (mild redness, rarely painful).
Rare but monitored: Gallbladder events (gallstones — associated with rapid weight loss in general, not specific to liraglutide), acute pancreatitis (very rare, under 0.3% in trials), thyroid C-cell concern (theoretical, based on rodent studies — no confirmed human signal in over a decade of use).
LEADER cardiovascular safety: The LEADER trial (n=9,340, median 3.8 years follow-up) established that liraglutide is not only cardiovascularly safe but protective — 13% reduction in major adverse cardiovascular events. This long-term safety data is unmatched by newer GLP-1 medications.
Contraindications: Personal or family history of medullary thyroid carcinoma (MTC) or MEN 2. Pregnancy or breastfeeding. History of pancreatitis requires careful evaluation. Same contraindications as all GLP-1 medications — screened during your consultation.
Daily compliance: The daily injection requirement means adherence is more demanding than weekly medications. Missing doses regularly reduces effectiveness. If you know you will struggle with a daily injection routine, a weekly medication (semaglutide or tirzepatide) may be more practical.
Malaysia Availability & Pricing
Saxenda: Available in Malaysia through specialist weight management clinics, endocrinology clinics, and select private hospitals. Not typically stocked at general practice clinics. Prescribed specifically for weight management. Approximately RM895 per month at the 3.0mg maintenance dose.
Victoza: More widely available through diabetes clinics and general endocrinology. Lower maximum dose (1.8mg) means less effective for weight loss. Approximately RM600-800/month. Some doctors may prescribe Victoza off-label at higher doses, but Saxenda is the proper formulation for weight management.
Cost advantage: At ~RM895/month, liraglutide (Saxenda) is the most affordable GLP-1 weight loss option in Malaysia. Compare to Ozempic (RM800-2,000), Wegovy (RM2,000-3,500), and Mounjaro (RM1,200-3,000). Over a 12-month treatment course, the savings are substantial.
Storage: Liraglutide pens must be refrigerated before first use (2-8 degrees C). Once in use, they can be kept at room temperature (up to 30 degrees C) for up to 30 days. Important in Malaysia's climate — do not leave pens in a hot car.
Peak Protocol connects you with doctors experienced in prescribing liraglutide for weight management, not just diabetes. We ensure proper titration guidance, regular follow-up monitoring, and help determine if liraglutide is the right GLP-1 choice for your specific goals, budget, and health profile.
Frequently Asked Questions
How do I get liraglutide (Saxenda) in Malaysia?
Prescription from a licensed Malaysian doctor is required. Most GPs are familiar with Victoza (for diabetes) but less comfortable prescribing Saxenda (for weight loss). Peak Protocol connects you with doctors experienced in metabolic weight management who can prescribe Saxenda at the proper 3.0mg weight-loss dose. Start with a WhatsApp consultation.
Is liraglutide legal in Malaysia?
Yes. Both Saxenda and Victoza are registered with Malaysia's NPRA and legally available with a valid prescription. All medications sourced through Peak Protocol come from licensed Malaysian pharmacies.
Should I choose liraglutide or semaglutide?
Choose liraglutide if: budget is a primary concern (~RM895 vs RM800-3,500), you prefer daily routine-based medication, you have moderate weight loss goals (10-20 kg), you value the longest safety track record, or you experienced significant GI issues with weekly semaglutide. Choose semaglutide if: maximum weight loss is the priority, you prefer weekly convenience, or budget is not the primary constraint. Your doctor can help determine the best fit.
How much weight will I lose on liraglutide?
Clinical trials show average weight loss of 8-12% of body weight over 56 weeks at the 3.0mg dose. For a 90 kg person, that is 7-11 kg. Some patients lose more, especially when combining medication with structured diet and exercise. Liraglutide produces less weight loss than semaglutide (15-20%) or tirzepatide (20-25%), but the results are clinically meaningful and well-sustained.
Can I switch from liraglutide to semaglutide later?
Yes. Many patients start with liraglutide for its lower cost and established safety, then switch to semaglutide or tirzepatide if they want greater weight loss. The transition is straightforward — stop liraglutide and begin semaglutide titration from the starting dose. Your doctor will manage the transition timing.
Is the daily injection painful?
The Saxenda pen uses a very fine needle (32-gauge, 4-5mm) that most users describe as barely noticeable — less painful than a blood sugar finger prick. The injection takes about 10 seconds. Rotate injection sites (abdomen, thigh, upper arm) to prevent local irritation. Most users report that after the first few injections, they barely think about it. The pen is pre-filled and does not require mixing or preparation.
What time of day should I inject liraglutide?
Liraglutide can be injected at any time of day — morning or evening, with or without food. The important thing is consistency: inject at approximately the same time each day. Some users prefer morning injection to get appetite suppression through the workday. Others prefer evening to reduce nighttime snacking. Experiment and see what works best for your routine.
What happens if I miss a dose?
If you miss a dose and it has been less than 12 hours since your usual injection time, take it as soon as you remember. If more than 12 hours have passed, skip the missed dose and take the next one at your regular time. Do not take a double dose. Occasional missed doses reduce effectiveness slightly but are not dangerous. If you miss multiple days, do not restart at the maintenance dose — consult your doctor about whether re-titration is needed.
Can liraglutide be used with other weight loss medications?
Liraglutide should NOT be combined with other GLP-1 medications (semaglutide, tirzepatide, dulaglutide). Combining GLP-1 agents increases side effects without proportional benefit. However, liraglutide can potentially be combined with other weight management approaches like metformin, naltrexone-bupropion (Contrave), or orlistat under careful medical supervision. Your doctor will advise on safe combinations based on your individual health profile.